Results 261 to 270 of about 32,734 (287)

Humoral and cytokine responses to a heterologous goatpox vaccine in Mithun (<i>Bos frontalis</i>): a longitudinal field study. [PDF]

Front Immunol
Reddy GBM, Ramesh V, Somagond YM, Goswami P, Ragulraj S, Lalzampuia H, Pal S, Nagaraj S, Tadakod S, Jabeen U, Bijalwan S, Ramakrishnan MA, Gulati BR, Girish PS.   +13 more
europepmc   +1 more source

Cross-Protection in PRRSV: Mechanisms, Limitations, and Implications for Vaccine Design. [PDF]

Pathogens
Raev SA, Cai L, Muro N, Madera R, Wang L, Shi J.   +5 more
europepmc   +1 more source

Trained immunity: consequences for the heterologous effects of BCG vaccination

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2015
A growing body of evidence from epidemiologic and immunologic studies have shown that in addition to target disease-specific effects, vaccines have heterologous effects towards unrelated pathogens. Like some other vaccines, bacille Calmette-Guerin (BCG) has shown in observational studies and randomized clinical trials to increase survival beyond the ...
Kleinnijenhuis, J., Crevel, R. van, Netea, M.G.   +2 more
openaire   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Heterologous vaccine effects

Vaccine, 2016
The heterologous or non-specific effects (NSEs) of vaccines, at times defined as "off-target effects" suggest that they can affect the immune response to organisms other than their pathogen-specific intended purpose. These NSEs have been the subject of clinical, immunological and epidemiological studies and are increasingly recognized as an important ...
Mitra Saadatian-Elahi, Peter Aaby, Frank Shann, Mihai G. Netea, Ofer Levy, Jacques Louis, Valentina Picot, Michael Greenberg, William Warren   +8 more
openaire   +3 more sources

Cowpea mosaic virus as a vaccine carrier of heterologous antigens

Molecular Biotechnology, 2001
The plant virus, cowpea mosaic virus (CPMV), has been developed as an expression and presentation system to display antigenic epitopes derived from a number of vaccine targets including infectious disease agents and tumors. These chimeric virus particles (CVPs) could represent a cost-effective and safe alternative to live replicating virus and ...
F R, Brennan, T D, Jones, W D, Hamilton
openaire   +2 more sources

Heterologous protection elicited by a live, attenuated, Leptospira vaccine

Veterinary Microbiology, 2018
A previously-described live, attenuated vaccine (M1352, serovar Manilae, serogroup Pyrogenes) was tested in the hamster model of infection for cross-protective immunity. The vaccine elicited strong, significant cross-protection against lethal infection by strains representing four serologically distinct leptospiral serovars (Grippotyphosa, Australis ...
Gerald L. Murray, Theeraya Simawaranon, Chamraj Kaewraemruaen, Ben Adler, Rasana W. Sermswan   +4 more
openaire   +2 more sources

Biochemical Analysis of the Blood of Cattle after Vaccination with a Heterologous Vaccine for Lumpy Skin Disease

Bulletin of Experimental Biology and Medicine, 2022
We studied the biochemical parameters of the blood of cattle after immunization against lumpy skin disease with a vaccine made from an attenuated heterologous goat pox virus (strain G20-LKV). Blood samples were obtained from animals on days 7, 14, and 21 after vaccination. The vaccine did not affect biochemical parameters of the blood.
Ye A, Bulatov, Zh Zh, Sametova, Sh S, Turyskeldi, Zh T, Amanova, K A, Shoraeva, Zh B, Kondibaeva, R T, Abitaev, A K, Ussembay   +7 more
openaire   +2 more sources

A prime–boost vaccination of mice with heterologous H5N1 strains

Vaccine, 2009
We evaluated the priming effect of an H5N1 pandemic vaccine in a mouse model to investigate strategies for influenza pandemic vaccination. For priming, an alum-adjuvanted inactivated whole H5N1 vaccine (NIBRG-14, clade 1) was used. As booster vaccines, several formulations of Indo05/05/2005(H5N1)PR8-IBCDC-RG2 vaccines (clades 2-1)were evaluated ...
Daisuke, Ikeno, Kazuhiko, Kimachi, Yasuhiro, Kudo, Shuro, Goto, Shigeyuki, Itamura, Takato, Odagiri, Masato, Tashiro, Yoichiro, Kino   +7 more
openaire   +2 more sources

Heterologe Vaccination gegen Superinfekte mit Tuberkelbakterien

1961
Fur Schutzimpfungen gegen bakterielle Infektionen werden homologe Vaccinen verwendet; dementsprechend gegen den tuberkulosen Infekt solche aus schwach virulenten Tuberkelbakterien. Der Vaccination mit heterologen (nicht-mycobakteriellen) Vaccinen hat man nur geringes Interesse geschenkt. Das ist berechtigt und verstandlich, soweit es sich um die Praxis
Enno Freerksen, Magdalena Rosenfeld, Ernst de Cuveland   +2 more
openaire   +1 more source

Heterologous Prime-Boost Vaccination in Tumor Immunotherapy

2004
Most of the vaccine strategies under development use multiple immunizations with the same agent such as a viral vector encoding a tumor antigen. More recently, the concept of heterologous prime-boost immunization has been tested in animal models. This strategy involves the sequential administration of different delivery vectors encoding the same ...
Michael J. Palmowski, Caroline Smith
openaire   +1 more source